{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,11,11]],"date-time":"2026-11-11T08:28:27Z","timestamp":1794385707615,"version":"4.9.0"},"reference-count":63,"publisher":"Springer Science and Business Media LLC","issue":"1","license":[{"start":{"date-parts":[[2017,11,2]],"date-time":"2017-11-02T00:00:00Z","timestamp":1509580800000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0"},{"start":{"date-parts":[[2017,11,2]],"date-time":"2017-11-02T00:00:00Z","timestamp":1509580800000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0"}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["Nat Commun"],"abstract":"<jats:title>Abstract<\/jats:title><jats:p>Exposure of human populations to bovine spongiform encephalopathy through contaminated food has resulted in &lt;250 cases of variant Creutzfeldt\u2013Jakob disease (vCJD). However, more than 99% of vCJD infections could have remained silent suggesting a long-term risk of secondary transmission particularly through blood. Here, we present experimental evidence that transfusion in mice and non-human primates of blood products from symptomatic and non-symptomatic infected donors induces not only vCJD, but also a different class of neurological impairments. These impairments can all be retransmitted to mice with a pathognomonic accumulation of abnormal prion protein, thus expanding the spectrum of known prion diseases. Our findings suggest that the intravenous route promotes propagation of masked prion variants according to different mechanisms involved in peripheral replication.<\/jats:p>","DOI":"10.1038\/s41467-017-01347-0","type":"journal-article","created":{"date-parts":[[2017,10,27]],"date-time":"2017-10-27T18:38:56Z","timestamp":1509129536000},"update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":28,"title":["Experimental transfusion of variant CJD-infected blood reveals previously uncharacterised prion disorder in mice and macaque"],"prefix":"10.1038","volume":"8","author":[{"given":"Emmanuel E.","family":"Comoy","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jacqueline","family":"Mikol","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Nina","family":"Jaffr\u00e9","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Vincent","family":"Lebon","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Etienne","family":"Levavasseur","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Nathalie","family":"Streichenberger","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Chryslain","family":"Sumian","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Armand","family":"Perret-Liaudet","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Marc","family":"Eloit","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Olivier","family":"Andreoletti","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"St\u00e9phane","family":"Ha\u00efk","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Philippe","family":"Hantraye","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jean-Philippe","family":"Deslys","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2017,11,2]]},"reference":[{"key":"1347_CR1","doi-asserted-by":"publisher","first-page":"185","DOI":"10.1093\/bmb\/66.1.185","volume":"66","author":"PG Smith","year":"2003","unstructured":"Smith, P. G. & Bradley, R. Bovine spongiform encephalopathy (BSE) and its epidemiology. Br. Med. Bull. \n                           66, 185\u2013198 (2003).","journal-title":"Br. Med. Bull."},{"key":"1347_CR2","doi-asserted-by":"publisher","DOI":"10.1371\/journal.pone.0094020","volume":"9","author":"CC Chen","year":"2014","unstructured":"Chen, C. C. & Wang, Y. H. Estimation of the exposure of the UK population to the bovine spongiform encephalopathy agent through dietary intake during the period 1980 to 1996. PLoS ONE \n                           9, e94020 (2014).","journal-title":"PLoS ONE"},{"key":"1347_CR3","doi-asserted-by":"publisher","first-page":"310","DOI":"10.1111\/vox.12371","volume":"110","author":"PJ Urwin","year":"2016","unstructured":"Urwin, P. J., Mackenzie, J. M., Llewelyn, C. A., Will, R. G. & Hewitt, P. E. Creutzfeldt-Jakob disease and blood transfusion: updated results of the UK Transfusion Medicine Epidemiology Review Study. Vox Sang. \n                           110, 310\u2013316 (2016).","journal-title":"Vox Sang."},{"key":"1347_CR4","doi-asserted-by":"publisher","first-page":"296","DOI":"10.1111\/j.1365-2516.2009.02181.x","volume":"16","author":"A Peden","year":"2010","unstructured":"Peden, A. et al. Variant CJD infection in the spleen of a neurologically asymptomatic UK adult patient with haemophilia. Haemophilia \n                           16, 296\u2013304 (2010).","journal-title":"Haemophilia"},{"key":"1347_CR5","doi-asserted-by":"publisher","first-page":"14","DOI":"10.1111\/j.1365-2141.2008.07376.x","volume":"144","author":"ML Turner","year":"2009","unstructured":"Turner, M. L. & Ludlam, C. A. An update on the assessment and management of the risk of transmission of variant Creutzfeldt-Jakob disease by blood and plasma products. Br. J. Haematol. \n                           144, 14\u201323 (2009).","journal-title":"Br. J. Haematol."},{"key":"1347_CR6","doi-asserted-by":"publisher","first-page":"529","DOI":"10.1016\/S0140-6736(04)16812-8","volume":"364","author":"L Gregori","year":"2004","unstructured":"Gregori, L. et al. Effectiveness of leucoreduction for removal of infectivity of transmissible spongiform encephalopathies from blood. Lancet \n                           364, 529\u2013531 (2004).","journal-title":"Lancet"},{"key":"1347_CR7","doi-asserted-by":"publisher","DOI":"10.1136\/bmj.f5675","volume":"347","author":"ON Gill","year":"2013","unstructured":"Gill, O. N. et al. Prevalent abnormal prion protein in human appendixes after bovine spongiform encephalopathy epizootic: large scale survey. BMJ \n                           347, f5675 (2013).","journal-title":"BMJ"},{"key":"1347_CR8","doi-asserted-by":"publisher","first-page":"2068","DOI":"10.1016\/S0140-6736(06)68930-7","volume":"367","author":"J Collinge","year":"2006","unstructured":"Collinge, J. et al. Kuru in the 21st century\u2012an acquired human prion disease with very long incubation periods. Lancet \n                           367, 2068\u20132074 (2006).","journal-title":"Lancet"},{"key":"1347_CR9","doi-asserted-by":"publisher","DOI":"10.3201\/eid1806.120116","volume":"18","author":"P Brown","year":"2012","unstructured":"Brown, P. et al. Iatrogenic Creutzfeldt-Jakob disease, final assessment. Emerg. Infect. Dis. \n                           18, 7 (2012).","journal-title":"Emerg. Infect. Dis."},{"key":"1347_CR10","unstructured":"Parker, A., Bennett, P., Daraktchiev, M. & SaBTO. Importation of Plasma as a vCJD Risk Reduction Measure: Reconsideration of \u2018Acceptable\u2019 Source Countries. http:\/\/www.gov.uk\/government\/publications\/sourcing-blood-plasma-for-import-into-the-uk (2013)."},{"key":"1347_CR11","doi-asserted-by":"publisher","first-page":"402","DOI":"10.1126\/science.275.5298.402","volume":"275","author":"CI Lasmezas","year":"1997","unstructured":"Lasmezas, C. I. et al. Transmission of the BSE agent to mice in the absence of detectable abnormal prion protein. Science \n                           275, 402\u2013405 (1997).","journal-title":"Science"},{"key":"1347_CR12","doi-asserted-by":"publisher","first-page":"1687","DOI":"10.1046\/j.0041-1132.2003.00586.x","volume":"43","author":"L Cervenakova","year":"2003","unstructured":"Cervenakova, L. et al. Similar levels of infectivity in the blood of mice infected with human-derived vCJD and GSS strains of transmissible spongiform encephalopathy. Transfusion \n                           43, 1687\u20131694 (2003).","journal-title":"Transfusion"},{"key":"1347_CR13","doi-asserted-by":"publisher","first-page":"943","DOI":"10.1126\/science.142303","volume":"197","author":"DC Gajdusek","year":"1977","unstructured":"Gajdusek, D. C. Unconventional viruses and the origin and disappearance of kuru. Science \n                           197, 943\u2013960 (1977).","journal-title":"Science"},{"key":"1347_CR14","doi-asserted-by":"publisher","first-page":"513","DOI":"10.1002\/ana.410350504","volume":"35","author":"P Brown","year":"1994","unstructured":"Brown, P. et al. Human spongiform encephalopathy: the National Institutes of Health series of 300 cases of experimentally transmitted disease. Ann. Neurol. \n                           35, 513\u2013529 (1994).","journal-title":"Ann. Neurol."},{"key":"1347_CR15","doi-asserted-by":"publisher","first-page":"743","DOI":"10.1038\/381743a0","volume":"381","author":"CI Lasmezas","year":"1996","unstructured":"Lasmezas, C. I. et al. BSE transmission to macaques. Nature \n                           381, 743\u2013744 (1996).","journal-title":"Nature"},{"key":"1347_CR16","doi-asserted-by":"publisher","first-page":"781","DOI":"10.1016\/S0140-6736(05)17985-9","volume":"365","author":"CI Lasmezas","year":"2005","unstructured":"Lasmezas, C. I. et al. Risk of oral infection with bovine spongiform encephalopathy agent in primates. Lancet \n                           365, 781\u2013783 (2005).","journal-title":"Lancet"},{"key":"1347_CR17","doi-asserted-by":"publisher","first-page":"652","DOI":"10.1111\/j.1537-2995.2006.00763.x","volume":"46","author":"VA Berardi","year":"2006","unstructured":"Berardi, V. A., Cardone, F., Valanzano, A., Lu, M. & Pocchiari, M. Preparation of soluble infectious samples from scrapie-infected brain: a new tool to study the clearance of transmissible spongiform encephalopathy agents during plasma fractionation. Transfusion \n                           46, 652\u2013658 (2006).","journal-title":"Transfusion"},{"key":"1347_CR18","doi-asserted-by":"publisher","first-page":"32","DOI":"10.1186\/s40478-017-0430-z","volume":"5","author":"C Bett","year":"2017","unstructured":"Bett, C. et al. Enhanced neuroinvasion by smaller, soluble prions. Acta Neuropathol. Commun. \n                           5, 32\u201342 (2017).","journal-title":"Acta Neuropathol. Commun."},{"key":"1347_CR19","doi-asserted-by":"publisher","first-page":"3724","DOI":"10.4049\/jimmunol.1103312","volume":"188","author":"A Link","year":"2012","unstructured":"Link, A. et al. Innate immunity mediates follicular transport of particulate but not soluble protein antigen. J. Immunol. \n                           188, 3724\u20133733 (2012).","journal-title":"J. Immunol."},{"key":"1347_CR20","doi-asserted-by":"publisher","first-page":"4142","DOI":"10.1073\/pnas.041490898","volume":"98","author":"CI Lasmezas","year":"2001","unstructured":"Lasmezas, C. I. et al. Adaptation of the bovine spongiform encephalopathy agent to primates and comparison with Creutzfeldt-Jakob disease: implications for human health. Proc. Natl Acad. Sci. USA \n                           98, 4142\u20134147 (2001).","journal-title":"Proc. Natl Acad. Sci. USA"},{"key":"1347_CR21","doi-asserted-by":"publisher","first-page":"262","DOI":"10.1046\/j.1365-2990.2003.00462.x","volume":"29","author":"DA Brown","year":"2003","unstructured":"Brown, D. A., Bruce, M. E. & Fraser, J. R. Comparison of the neuropathological characteristics of bovine spongiform encephalopathy (BSE) and variant Creutzfeldt-Jakob disease (vCJD) in mice. Neuropathol. Appl. Neurobiol. \n                           29, 262\u2013272 (2003).","journal-title":"Neuropathol. Appl. Neurobiol."},{"key":"1347_CR22","doi-asserted-by":"publisher","first-page":"930","DOI":"10.1126\/science.1138718","volume":"318","author":"J Collinge","year":"2007","unstructured":"Collinge, J. & Clarke, A. R. A general model of prion strains and their pathogenicity. Science \n                           318, 930\u2013936 (2007).","journal-title":"Science"},{"key":"1347_CR23","doi-asserted-by":"publisher","first-page":"1128","DOI":"10.1038\/nature07761","volume":"457","author":"J Lauren","year":"2009","unstructured":"Lauren, J., Gimbel, D. A., Nygaard, H. B., Gilbert, J. W. & Strittmatter, S. M. Cellular prion protein mediates impairment of synaptic plasticity by amyloid-beta oligomers. Nature \n                           457, 1128\u20131132 (2009).","journal-title":"Nature"},{"key":"1347_CR24","doi-asserted-by":"publisher","first-page":"1091","DOI":"10.1126\/science.1187790","volume":"327","author":"S Supattapone","year":"2010","unstructured":"Supattapone, S. Biochemistry. What makes a prion infectious? Science \n                           327, 1091\u20131092 (2010).","journal-title":"Science"},{"key":"1347_CR25","doi-asserted-by":"publisher","first-page":"904","DOI":"10.1093\/nar\/gku1342","volume":"43","author":"A Bravard","year":"2015","unstructured":"Bravard, A. et al. The prion protein is critical for DNA repair and cell survival after genotoxic stress. Nucleic Acids Res. \n                           43, 904\u2013916 (2015).","journal-title":"Nucleic Acids Res."},{"key":"1347_CR26","doi-asserted-by":"publisher","first-page":"7611","DOI":"10.1128\/JVI.77.13.7611-7622.2003","volume":"77","author":"R Chiesa","year":"2003","unstructured":"Chiesa, R. et al. Molecular distinction between pathogenic and infectious properties of the prion protein. J. Virol. \n                           77, 7611\u20137622 (2003).","journal-title":"J. Virol."},{"key":"1347_CR27","doi-asserted-by":"publisher","first-page":"2535","DOI":"10.1128\/JVI.03082-12","volume":"87","author":"S Hannaoui","year":"2013","unstructured":"Hannaoui, S. et al. Prion propagation and toxicity occur in vitro with two-phase kinetics specific to strain and neuronal type. J. Virol. \n                           87, 2535\u20132548 (2013).","journal-title":"J. Virol."},{"key":"1347_CR28","doi-asserted-by":"publisher","DOI":"10.1371\/journal.pone.0071081","volume":"8","author":"AG Timmes","year":"2013","unstructured":"Timmes, A. G., Moore, R. A., Fischer, E. R. & Priola, S. A. Recombinant prion protein refolded with lipid and RNA has the biochemical hallmarks of a prion but lacks in vivo infectivity. PLoS ONE \n                           8, e71081 (2013).","journal-title":"PLoS ONE"},{"key":"1347_CR29","doi-asserted-by":"publisher","first-page":"453","DOI":"10.1099\/vir.0.045922-0","volume":"94","author":"S Krasemann","year":"2013","unstructured":"Krasemann, S., Neumann, M., Szalay, B., Stocking, C. & Glatzel, M. Protease-sensitive prion species in neoplastic spleens of prion-infected mice with uncoupling of PrP(Sc) and prion infectivity. J. Gen. Virol. \n                           94, 453\u2013463 (2013).","journal-title":"J. Gen. Virol."},{"key":"1347_CR30","doi-asserted-by":"publisher","first-page":"5895","DOI":"10.1128\/JVI.03469-12","volume":"87","author":"K Dobie","year":"2013","unstructured":"Dobie, K. & Barron, R. Dissociation between transmissible spongiform encephalopathy (TSE) infectivity and proteinase K-resistant PrP(Sc) levels in peripheral tissue from a murine transgenic model of TSE disease. J. Virol. \n                           87, 5895\u20135903 (2013).","journal-title":"J. Virol."},{"key":"1347_CR31","doi-asserted-by":"publisher","DOI":"10.1371\/journal.ppat.1004796","volume":"11","author":"I Bouybayoune","year":"2015","unstructured":"Bouybayoune, I. et al. Transgenic fatal familial insomnia mice indicate prion infectivity-independent mechanisms of pathogenesis and phenotypic expression of disease. PLoS Pathog. \n                           11, e1004796 (2015).","journal-title":"PLoS Pathog."},{"key":"1347_CR32","volume":"10","author":"J Greenlee","year":"2016","unstructured":"Greenlee, J., Kunkle, B., Smith, J. D. & Greenlee, H. Scrapie in swine: a diagnostic challenge. Prion \n                           10, S16 (2016).","journal-title":"Prion"},{"key":"1347_CR33","volume":"10","author":"S Dudas","year":"2016","unstructured":"Dudas, S. et al. Oral transmission of classical BSE to adult cattle. Prion \n                           10, S118 (2016).","journal-title":"Prion"},{"key":"1347_CR34","doi-asserted-by":"publisher","first-page":"292","DOI":"10.1056\/NEJMc1610003","volume":"376","author":"T Mok","year":"2017","unstructured":"Mok, T. et al. Variant Creutzfeldt-Jakob disease in a patient with heterozygosity at PRNP codon 129. N. Engl. J. Med. \n                           376, 292\u2013294 (2017).","journal-title":"N. Engl. J. Med."},{"key":"1347_CR35","doi-asserted-by":"publisher","first-page":"147","DOI":"10.4161\/pri.19430","volume":"6","author":"CD Orru","year":"2012","unstructured":"Orru, C. D., Wilham, J. M., Vascellari, S., Hughson, A. G. & Caughey, B. New generation QuIC assays for prion seeding activity. Prion \n                           6, 147\u2013152 (2012).","journal-title":"Prion"},{"key":"1347_CR36","doi-asserted-by":"publisher","DOI":"10.1371\/journal.ppat.1000421","volume":"5","author":"MA Barria","year":"2009","unstructured":"Barria, M. A., Mukherjee, A., Gonzalez-Romero, D., Morales, R. & Soto, C. De novo generation of infectious prions in vitro produces a new disease phenotype. PLoS Pathog. \n                           5, e1000421 (2009).","journal-title":"PLoS Pathog."},{"key":"1347_CR37","doi-asserted-by":"publisher","first-page":"4768","DOI":"10.1096\/fj.13-233965","volume":"27","author":"Z Zhang","year":"2013","unstructured":"Zhang, Z. et al. De novo generation of infectious prions with bacterially expressed recombinant prion protein. FASEB J. \n                           27, 4768\u20134775 (2013).","journal-title":"FASEB J."},{"key":"1347_CR38","doi-asserted-by":"publisher","first-page":"E1244","DOI":"10.1073\/pnas.1111255108","volume":"108","author":"M Klingeborn","year":"2011","unstructured":"Klingeborn, M., Race, B., Meade-White, K. D. & Chesebro, B. Lower specific infectivity of protease-resistant prion protein generated in cell-free reactions. Proc. Natl Acad. Sci. USA \n                           108, E1244\u2013E1253 (2011).","journal-title":"Proc. Natl Acad. Sci. USA"},{"key":"1347_CR39","doi-asserted-by":"publisher","first-page":"712","DOI":"10.3201\/eid1905.120274","volume":"19","author":"E Holznagel","year":"2013","unstructured":"Holznagel, E. et al. Foodborne transmission of bovine spongiform encephalopathy to nonhuman primates. Emerg. Infect. Dis. \n                           19, 712\u2013720 (2013).","journal-title":"Emerg. Infect. Dis."},{"key":"1347_CR40","doi-asserted-by":"publisher","first-page":"355","DOI":"10.1001\/archneur.57.3.355","volume":"57","author":"JD Katz","year":"2000","unstructured":"Katz, J. D. & Ropper, A. H. Progressive necrotic myelopathy: clinical course in 9 patients. Arch. Neurol. \n                           57, 355\u2013361 (2000).","journal-title":"Arch. Neurol."},{"issue":"Pt 6","key":"1347_CR41","doi-asserted-by":"publisher","first-page":"1357","DOI":"10.1093\/brain\/117.6.1357","volume":"117","author":"JB Cavanagh","year":"1994","unstructured":"Cavanagh, J. B. & Harding, B. N. Pathogenic factors underlying the lesions in Leigh\u2019s disease. Tissue responses to cellular energy deprivation and their clinico-pathological consequences. Brain \n                           117(Pt 6), 1357\u20131376 (1994).","journal-title":"Brain"},{"key":"1347_CR42","doi-asserted-by":"publisher","first-page":"482","DOI":"10.1097\/NEN.0000000000000195","volume":"74","author":"NJ Lake","year":"2015","unstructured":"Lake, N. J., Bird, M. J., Isohanni, P. & Paetau, A. Leigh syndrome: neuropathology and pathogenesis. J. Neuropathol. Exp. Neurol. \n                           74, 482\u2013492 (2015).","journal-title":"J. Neuropathol. Exp. Neurol."},{"key":"1347_CR43","doi-asserted-by":"publisher","first-page":"537","DOI":"10.1016\/j.autrev.2006.02.008","volume":"5","author":"RN Mandler","year":"2006","unstructured":"Mandler, R. N. Neuromyelitis optica - Devic\u2019s syndrome, update. Autoimmun. Rev. \n                           5, 537\u2013543 (2006).","journal-title":"Autoimmun. Rev."},{"key":"1347_CR44","doi-asserted-by":"publisher","first-page":"3384","DOI":"10.1093\/brain\/awl258","volume":"129","author":"S Vucic","year":"2006","unstructured":"Vucic, S. et al. Facial onset sensory and motor neuronopathy (FOSMN syndrome): a novel syndrome in neurology. Brain \n                           129, 3384\u20133390 (2006).","journal-title":"Brain"},{"key":"1347_CR45","doi-asserted-by":"publisher","first-page":"950","DOI":"10.1136\/jnnp.65.6.950","volume":"65","author":"MT Hu","year":"1998","unstructured":"Hu, M. T., Ellis, C. M., Al-Chalabi, A., Leigh, P. N. & Shaw, C. E. Flail arm syndrome: a distinctive variant of amyotrophic lateral sclerosis. J. Neurol. Neurosurg. Psychiatry \n                           65, 950\u2013951 (1998).","journal-title":"J. Neurol. Neurosurg. Psychiatry"},{"key":"1347_CR46","doi-asserted-by":"publisher","first-page":"1087","DOI":"10.1212\/01.wnl.0000345041.83406.a2","volume":"72","author":"LC Wijesekera","year":"2009","unstructured":"Wijesekera, L. C. et al. Natural history and clinical features of the flail arm and flail leg ALS variants. Neurology \n                           72, 1087\u20131094 (2009).","journal-title":"Neurology"},{"key":"1347_CR47","doi-asserted-by":"publisher","first-page":"697","DOI":"10.1002\/ana.21420","volume":"63","author":"P Gambetti","year":"2008","unstructured":"Gambetti, P. et al. A novel human disease with abnormal prion protein sensitive to protease. Ann. Neurol. \n                           63, 697\u2013708 (2008).","journal-title":"Ann. Neurol."},{"key":"1347_CR48","doi-asserted-by":"publisher","DOI":"10.1186\/2051-5960-1-72","volume":"1","author":"GG Kovacs","year":"2013","unstructured":"Kovacs, G. G. et al. Rapidly progressive dementia with thalamic degeneration and peculiar cortical prion protein immunoreactivity, but absence of proteinase K resistant PrP: a new disease entity? Acta Neuropathol. Commun. \n                           1, 72 (2013).","journal-title":"Acta Neuropathol. Commun."},{"key":"1347_CR49","doi-asserted-by":"publisher","first-page":"1904","DOI":"10.1056\/NEJMoa1214747","volume":"369","author":"S Mead","year":"2013","unstructured":"Mead, S. et al. A novel prion disease associated with diarrhea and autonomic neuropathy. N. Engl. J. Med. \n                           369, 1904\u20131914 (2013).","journal-title":"N. Engl. J. Med."},{"key":"1347_CR50","doi-asserted-by":"publisher","first-page":"498","DOI":"10.1038\/39057","volume":"389","author":"ME Bruce","year":"1997","unstructured":"Bruce, M. E. et al. Transmissions to mice indicate that \u201cnew variant\u201d CJD is caused by the BSE agent. Nature \n                           389, 498\u2013501 (1997).","journal-title":"Nature"},{"key":"1347_CR51","doi-asserted-by":"publisher","first-page":"1125","DOI":"10.3201\/eid1907.120438","volume":"19","author":"J Montag","year":"2013","unstructured":"Montag, J., Schulz-Schaeffer, W., Schrod, A., Hunsmann, G. & Motzkus, D. Asynchronous onset of clinical disease in BSE-infected macaques. Emerg. Infect. Dis. \n                           19, 1125\u20131127 (2013).","journal-title":"Emerg. Infect. Dis."},{"key":"1347_CR52","doi-asserted-by":"publisher","first-page":"422","DOI":"10.1016\/S0140-6736(04)15487-1","volume":"363","author":"C Herzog","year":"2004","unstructured":"Herzog, C. et al. Tissue distribution of bovine spongiform encephalopathy agent in primates after intravenous or oral infection. Lancet \n                           363, 422\u2013428 (2004).","journal-title":"Lancet"},{"key":"1347_CR53","doi-asserted-by":"publisher","first-page":"1231","DOI":"10.1111\/trf.12999","volume":"55","author":"N Lescoutra-Etchegaray","year":"2015","unstructured":"Lescoutra-Etchegaray, N. et al. Evaluation of the protection of primates transfused with variant Creutzfeldt-Jakob disease-infected blood products filtered with prion removal devices: a 5-year update. Transfusion \n                           55, 1231\u20131241 (2015).","journal-title":"Transfusion"},{"key":"1347_CR54","doi-asserted-by":"publisher","DOI":"10.1371\/journal.pone.0003017","volume":"3","author":"EE Comoy","year":"2008","unstructured":"Comoy, E. E. et al. Atypical BSE (BASE) transmitted from asymptomatic aging cattle to a primate. PLoS ONE \n                           3, e3017 (2008).","journal-title":"PLoS ONE"},{"key":"1347_CR55","doi-asserted-by":"publisher","first-page":"321","DOI":"10.1097\/00005072-199904000-00002","volume":"58","author":"F Gray","year":"1999","unstructured":"Gray, F. et al. Neuronal apoptosis in Creutzfeldt-Jakob disease. J. Neuropathol. Exp. Neurol. \n                           58, 321\u2013328 (1999).","journal-title":"J. Neuropathol. Exp. Neurol."},{"key":"1347_CR56","doi-asserted-by":"publisher","first-page":"8462","DOI":"10.1128\/JVI.77.15.8462-8469.2003","volume":"77","author":"A Barret","year":"2003","unstructured":"Barret, A. et al. Evaluation of quinacrine treatment for prion diseases. J. Virol. \n                           77, 8462\u20138469 (2003).","journal-title":"J. Virol."},{"key":"1347_CR57","doi-asserted-by":"publisher","DOI":"10.1051\/vetres:2008008","volume":"39","author":"MH Groschup","year":"2008","unstructured":"Groschup, M. H. & Buschmann, A. Rodent models for prion diseases. Vet. Res. \n                           39, 32 (2008).","journal-title":"Vet. Res."},{"key":"1347_CR58","doi-asserted-by":"publisher","first-page":"114","DOI":"10.3201\/eid2001.130353","volume":"20","author":"JY Douet","year":"2014","unstructured":"Douet, J. Y. et al. Detection of infectivity in blood of persons with variant and sporadic Creutzfeldt-Jakob disease. Emerg. Infect. Dis. \n                           20, 114\u2013117 (2014).","journal-title":"Emerg. Infect. Dis."},{"key":"1347_CR59","doi-asserted-by":"publisher","DOI":"10.1371\/journal.ppat.1004202","volume":"10","author":"C Lacroux","year":"2014","unstructured":"Lacroux, C. et al. Preclinical detection of variant CJD and BSE prions in blood. PLoS Pathog. \n                           10, e1004202 (2014).","journal-title":"PLoS Pathog."},{"key":"1347_CR60","doi-asserted-by":"publisher","first-page":"11247","DOI":"10.1074\/jbc.M407006200","volume":"280","author":"C Feraudet","year":"2005","unstructured":"Feraudet, C. et al. Screening of 145 anti-PrP monoclonal antibodies for their capacity to inhibit PrPSc replication in infected cells. J. Biol. Chem. \n                           280, 11247\u201311258 (2005).","journal-title":"J. Biol. Chem."},{"key":"1347_CR61","doi-asserted-by":"publisher","DOI":"10.1186\/1746-6148-2-19","volume":"2","author":"JP Langeveld","year":"2006","unstructured":"Langeveld, J. P. et al. Rapid and discriminatory diagnosis of scrapie and BSE in retro-pharyngeal lymph nodes of sheep. BMC Vet. Res. \n                           2, 19 (2006).","journal-title":"BMC Vet. Res."},{"key":"1347_CR62","doi-asserted-by":"publisher","DOI":"10.1371\/journal.ppat.1001217","volume":"6","author":"JM Wilham","year":"2010","unstructured":"Wilham, J. M. et al. Rapid end-point quantitation of prion seeding activity with sensitivity comparable to bioassays. PLoS Pathog. \n                           6, e1001217 (2010).","journal-title":"PLoS Pathog."},{"key":"1347_CR63","doi-asserted-by":"publisher","first-page":"408","DOI":"10.1002\/jmri.20511","volume":"23","author":"J Valette","year":"2006","unstructured":"Valette, J. et al. B(0) homogeneity throughout the monkey brain is strongly improved in the sphinx position as compared to the supine position. J. Magn. Reson. Imaging \n                           23, 408\u2013412 (2006).","journal-title":"J. Magn. Reson. Imaging"}],"container-title":["Nature Communications"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/www.nature.com\/articles\/s41467-017-01347-0.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/www.nature.com\/articles\/s41467-017-01347-0","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/www.nature.com\/articles\/s41467-017-01347-0.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2022,12,22]],"date-time":"2022-12-22T22:12:32Z","timestamp":1671747152000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.nature.com\/articles\/s41467-017-01347-0"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2017,11,2]]},"references-count":63,"journal-issue":{"issue":"1","published-online":{"date-parts":[[2017,12]]}},"alternative-id":["1347"],"URL":"https:\/\/doi.org\/10.1038\/s41467-017-01347-0","relation":{},"ISSN":["2041-1723"],"issn-type":[{"value":"2041-1723","type":"electronic"}],"subject":[],"published":{"date-parts":[[2017,11,2]]},"assertion":[{"value":"5 January 2017","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"11 September 2017","order":2,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"2 November 2017","order":3,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"The authors declare no competing financial interests.","order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Competing interests"}}],"article-number":"1268"}}